RCS-4
RCS-4, or 1-pentyl-3-(4-methoxybenzoyl)indole, is a synthetic cannabinoid drug sold under the names SR-19, BTM-4, or Eric-4 (later shortened to E-4), but originally, OBT-199. As with all other research chemicals, human use is not encouraged or recommended. Little data exist on this drug, and even without solid data chronic usage is recommended against.
Legality
RCS-4 was banned in Sweden on 1 October 2010 as a hazardous good harmful to health, after being identified as an ingredient in "herbal" synthetic cannabis products.[2][3] It was outlawed in Denmark on 11 March 2011.[4] In August 2011, New Zealand added not only RCS-4 but also its 1-butyl homologue, and the 2-methoxybenzoyl isomers of both these compounds, to a temporary class drug schedule (i.e. equivalent to Class C but reviewed after 12 months, and with personal possession and use of small amounts decriminalised), which was newly created under the Misuse of Drugs Amendment Act 2011 passed a week earlier.[5][6][7]
See also
References
- ^ = WDU20111050614 "Ustawa z dnia 15 kwietnia 2011 r. o zmianie ustawy o przeciwdzia艂aniu narkomanii ( Dz.U. 2011 nr 105 poz. 614 )". Internetowy System Akt贸w Prawnych. http://isap.sejm.gov.pl/DetailsServlet?id = WDU20111050614. Retrieved 12 June 2011.
- ^ Swedish Code of Statutes Regulation (2010:1086).
- ^ Swedish Code of Statutes Regulation (2010:1086). (pdf)
- ^ http://laegemiddelstyrelsen.dk/~/media/AC4F04EB48F74523A76BA84DAB9B6067.ashx
- ^ "Kronic ban passed by Parliament". The New Zealand Herald. NZPA. 4 August 2011. http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=10742964. Retrieved 4 November 2011.
- ^ "Synthetic cannabis off shelves by Wednesday". The New Zealand Herald. NZPA. 9 August 2011. http://www.nzherald.co.nz/nz/news/article.cfm?c_id=1&objectid=10743976. Retrieved 4 November 2011.
- ^ New Zealand Gazette. Tuesday 9 August 2011. Issue No 122, pp 3365-3366. Departmental Notices. Health. Misuse of Drugs Act 1975. Temporary Class Drug Notice.
|
|
Plant cannabinoids |
|
|
Cannabinoid metabolites |
|
|
Endogenous cannabinoids |
|
|
Synthetic cannabinoid
receptor agonists |
Classical cannabinoids
(Dibenzopyrans)
|
|
|
Nonclassical cannabinoids
|
|
|
Benzoylindoles
|
|
|
Naphthoylindoles
|
|
|
Naphthylmethylindoles
|
JWH-175 路 JWH-184 路 JWH-185 路 JWH-192 路 JWH-194 路 JWH-195 路 JWH-196 路 JWH-197 路 JWH-199
|
|
Phenylacetylindoles
|
|
|
Naphthoylpyrroles
|
|
|
Eicosanoids
|
|
|
Others
|
|
|
|
Allosteric modulators of
cannabinoid receptors |
|
|
Endocannabinoid
activity enhancers |
|
|
Cannabinoid receptor
antagonists and
inverse agonists |
|
|